Combination of two hormones increases height in girls with Turner syndrome

March 30, 2011

Giving girls with Turner syndrome low doses of estrogen, as well as growth hormone, years before the onset of puberty, increases their height and offers a wealth of other benefits, say a team of researchers led by Thomas Jefferson University. Their report is published in the March 31st issue of The New England Journal of Medicine (NEJM).

The study, which took more than 20 years to complete, will change the practice of treating girls with , says the study's lead author, Judith Ross, M.D., professor of Pediatrics at Jefferson Medical College of Thomas Jefferson University and AI DuPont Hospital for Children.

"Our goal is to improve the health and lives of girls and women with Turner syndrome or with other disorders that interrupt normal ovarian function," says Dr. Ross. "This study shows that our strategy accomplishes that."

Currently, most girls with Turner's syndrome receive only at the onset of puberty, she says. Turner syndrome, which the National Institutes of Health (NIH) says
occurs in 1 out of 2,500 female births worldwide, develops when a female (X) sex chromosome is missing in cells or is abnormal. These girls are typically of short stature and have a loss of ovarian function.

The findings are validation of a theory that Dr. Ross and her colleagues proposed in the NEJM 25 years ago. (She was then completing a fellowship at the NIH.) They suggested that typically developing girls produce small amounts of estrogen before puberty, and that in girls with Turner syndrome, a combination of very low doses of estrogen as well as growth hormone would work synergistically to increase height and improve overall cognitive functioning.

"The goal was to mimic what happens with in normal ovarian development, not to induce puberty," says Dr. Ross.

But the notion was controversial, she adds. "People thought that estrogen use at an early age in these patients could cause growth plates to fuse and to stop development – just as you see in a typically developing teenage girl who has a pubertal growth spurt and then stops growing."

Testing such a theory required a rigorous placebo-controlled clinical trial that could follow girls with Turner syndrome from childhood through adolescence and pubertal development until adult height was attained.

In this study, 149 girls with Turner syndrome, ages 5-12 years old, who were treated at Thomas Jefferson University Hospital or at the National Institutes of Health between 1987 and 2003, were randomized to one of four groups: placebo (no growth hormone or estrogen), growth hormone alone, estrogen alone, or growth hormone and estrogen in combination.

The amount of estrogen administered to girls randomized to receive it was only
1/50th of the dose the girls would be given once they reached puberty, Dr. Ross says.

The study showed that girls who started using the low dose estrogen at the average age of nine and who also used growth hormone grew an average of 3 inches taller than girls who didn't use growth hormone, or girls treated with only low dose estrogen. Girls treated with growth hormone alone were an inch shorter than the combination treatment group. Not only did estrogen increase the girl's height, it also improved psychosocial and , Dr. Ross says. Once the girls reached puberty, they were all treated with higher doses of estrogen.

According to current standard medical treatment, girls with Turner syndrome are treated with higher doses of growth hormone, at more frequent intervals, than was used in this study; consequently today's patients are taller than in this study. "It should be noted that adult height within the normal range was attained in 40 percent of growth-hormone-treated patients in this study but in only 4 percent of none-growth-hormone-treated patients," Dr. Ross says. "This research also shows that use of low dose estrogen is synergistic with growth hormone.

"There is a place for estrogen replacement prior to puberty in girls who need it, and we have made the case that replacing it earlier in these children is very beneficial," she says.

The findings may also benefit girls whose ovarian function has been damaged by chemotherapy or surgical removal, or other disorders, Dr. Ross adds.

Related Stories

Recommended for you

Long-lasting blood vessel repair in animals via stem cells

October 23, 2017
Stem cell researchers at Emory University School of Medicine have made an advance toward having a long-lasting "repair caulk" for blood vessels. The research could form the basis of a treatment for peripheral artery disease, ...

Synthetic hydrogels deliver cells to repair intestinal injuries

October 23, 2017
By combining engineered polymeric materials known as hydrogels with complex intestinal tissue known as organoids - made from human pluripotent stem cells - researchers have taken an important step toward creating a new technology ...

Study reveals connection between microbiome and autoimmune disorders

October 23, 2017
Many people associate the word "bacteria" with something dirty and disgusting. Dr. Pere Santamaria disagrees. Called the microbiome, the bacteria in our bodies have all kinds of positive effects on our health, Santamaria ...

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.